Contingent Share Offering

A contingent share offering is an issuance of equity where shares are delivered to the recipient (often an employee, partner, or seller in an M&A deal) only if specified performance conditions or milestones are met.

Basic mechanics

In a contingent share offering, the recipient is promised X shares if condition Y is met by date Z. Conditions can include:

• Revenue or earnings targets: The company hits $50M revenue by year-end; 10,000 shares deliver.
• Product milestones: A drug gets FDA approval; founders receive equity tranches.
• Acquisition integration: If acquired company retains 80% of customer base post-closing, original employees split $10M in earnout shares.
• Market performance: Stock price exceeds $150 for 30 consecutive trading days; employee receives additional grant.

The recipient may not be issued shares upfront. Instead, they receive a contractual promise that shares will be issued upon achievement. This defers equity dilution until risk is validated.

Use case: M&A earnouts

The classic application is the earnout provision in a merger or acquisition. Seller wants $100M; buyer wants to pay less if the business underperforms post-close.

Deal structure: Buyer pays $70M cash at close plus up to $30M in shares (or cash) if the seller company hits EBITDA targets in years 2–3. The seller has incentive to stay and execute; the buyer has downside protection.

If targets are hit, seller receives stock (or cash) worth $30M. If targets are missed, seller receives nothing—all dilution potential is avoided. The buyer benefits from the seller’s continued effort and alignment with post-acquisition reality.

Use case: Executive compensation

Companies sometimes grant “performance shares” that vest only if ROIC exceeds 10% or EPS grows 15% annually. The executive receives no shares if the company underperforms. This ties reward to actual creation of shareholder value, not mere passage of time.

Unlike restricted stock (which vests by schedule) or options (which require exercise), performance shares deliver shares directly on condition satisfaction. There is no strike price; the recipient gets equity for free if the goal is achieved.

Tax consequences

At delivery: If a condition is met and shares are issued, the fair market value at issuance is ordinary income to the recipient (assuming performance shares under ASC 718). A $100 share price on 10,000 shares = $1M ordinary income.

At sale: Any appreciation from delivery date to sale date is long-term capital gain if held >1 year. Any depreciation is a capital loss.

No cash paid: Because the recipient did not pay cash to receive the shares, the entire FMV is income—not just the gain.

Accounting complexities

Contingent shares are a headache for accountants. Under ASC 718, performance share grants are marked-to-market at each reporting date until the condition is satisfied or the grant expires.

Example: On January 1, you grant 10,000 performance shares worth $100 each ($1M). If the stock price falls to $80 by quarter-end, the liability remeasures to $800K, reducing compensation expense. If the price rises to $120, the liability rises to $1.2M, increasing expense. This volatility can swamp reported earnings in companies with large earnouts or performance share programs.

Risks to the recipient

Milestone miss: If conditions are not met, recipient receives zero shares. All upside is forfeited. This creates powerful incentive to achieve targets but also single-point-of-failure risk.

Moving goalposts: In some deals, targets are negotiated downward post-close (“we agree the market has changed”). The recipient may fight, or accept dilution of the payout.

Clawback: Some earnouts include a “true-up” or clawback. If the company initially hits targets in year 2, shares deliver. But if year-3 results disappoint, the company can claw back some or all shares. This is rare but happens in large M&A.

Liquidity delay: If a private company grants contingent shares with a 3-year milestone, the recipient cannot sell shares until condition is met and a liquidity event occurs (IPO or sale). Multi-year waits are common.

Strategic use by buyers and sellers

For buyers: Contingent shares reduce upfront cash required. A buyer paying 7x revenue for a software company (standard multiple) might pay 6x upfront, with 1x contingent on revenue retention. This reduces buyout cost and aligns seller incentives.

For sellers: Earnouts are a bet on their own execution. If the founder truly believes the business will grow, earnout upside can exceed cash downside. But it also means you stay on as an employee (often at lower salary than a typical hire), taking operational risk.

Sellers often dislike earnouts because targets can move, acquirers can change strategy, or synergies claimed at LOI-signing may not materialize. The seller is taking execution risk post-close on behalf of the buyer.

Comparison to other deferred payment structures

Earnout provisions in cash are similar but the recipient gets cash (not shares) if targets hit. Contingent shares deliver equity and create long-term alignment (seller holds shares after close). Cash earnouts are simpler but the seller exits immediately post-close.

Restricted stock is not contingent—it vests on a time schedule regardless of performance. Contingent shares are performance-gated, making them a stronger incentive alignment tool.

Options grant the right to buy shares; contingent shares grant the shares directly upon condition satisfaction, with no exercise required.

When contingent shares make sense

They work well when:

• Uncertainty around a company is high (startup integration, product risk).
• Recipient believes deeply in upcoming milestones.
• Alignment of incentives is critical (founder stay-on in an acquisition).
• The company wants to preserve cash at close.

They backfire when:

• Milestones are unachievable or moving-target.
• The recipient has no control over outcomes (acquired into a larger company, loses autonomy).
• The acquiring company intentionally sabotages targets to avoid payout.